Nanotechnology Databases

Comprehensive databases for nanomaterials, events, products,
companies, research labs, degree programs and publications


Nanobiotechnology and Nanomedicine Companies


Showing results 1 - 25 of 49 for companies in category Biomaterials:

The firm commercializes a family of self-assembling nanoscale scaffolds called PuraMatrix. 3DM's materials assemble upon injection into nanofibers, serving as a scaffold for tissue regeneration.
Anteo Diagnostics specialises in the development and commercialisation of proprietary surface coatings for applications in the diagnostics and biotech industries. With Mix&Go we have developed ?molecular glues? which are used by our partners and customers to immobilize delicate biological molecules such as antibodies to synthetic surfaces.
AnyGen develops bio-new drugs and essential materials, especially new drug candidates based on physiologically active peptides, biologically functional materials, and chemical nanomaterials.
The company develops biomedical nanoparticle technology and products for research and treatment of human disease. They are developing NanoElectroPlex™, a proprietary tissue selective nanoparticle platform technology based on biodegradable macromolecular carriers.
The company has developed enabling nanotechnologies for the production of protein nanoparticles, polymer nanospheres and phospholipid nanosomes for the enhanced delivery of drugs.
ApoLife has developed platform yeast expression technologies for accelerated development of therapeutic antibodies (glycosylated and aglycosylated), antibody fragments, fusion proteins and next generation antibodies and subunit vaccines through its proprietary Twin Cassette yeast system.
Develops a nanostructured material that stops bleeding almost instantly.
Arrayit Corporation empowers the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure.
Provides labelled and chemically modified oligonucleotide scaffolds for nanotechnology applications.
A biotechnology company with a strong technology platform and a unique expertise in exploiting bioactive molecules from venomous animals and other natural sources.
AuraSense's uniquely engineered nanoparticles possess unparalleled biocompatibility and versatility as therapeutics and as novel assays within live cells. They hold great promise for combating the most threatening diseases, including heart disease, cancer, and bacterial infection.
BIND Biosciences, Inc. is a biopharmaceutical company developing therapeutic targeted nanoparticles.
The company is a service partner for all aspects of oligonucleotides. It developed and produced the world's first and only translucent orthodontic systems using novel nanotechnology polymer composite products.
Dental implant technology with nanoscale coatings.
A life sciences R&D company with a special focus on skin cell biology. The company has established proprietary technologies for nano-liposomal formulation techniques.
Celsense is a biotechnology company offering novel MRI contrast agents (fluorochemical nanoparticles) that allow scientists and clinicians to monitor the position and quantity of transplanted cells non-invasively in vivo.
The company develops and sells tools for biomedical research based on nanotechnologies. Our products range from nanoparticles in suspensions to engineered surfaces for applications within stem cell research.
Applies nanotechnology to the design and manufacture of pumps, coatings and micro-needle arrays.
The company's mission is to develop and license R&D projects in Nanotechnology applied to Life Sciences. Endor is also developing pioneer in-house projects in novel Nanomaterials.
Worldwide company discovers, manufactures and markets molecular biology products and provides custom & OEM manufacturing service for pharma, diagnostic & life science research markets.
Develops a family of nanocomposite materials designed to increase mechanical performance in medical applications.
The company is engaged in R&D and production of nanomaterials and nanomaterials production equipment. Production program covers mostly antibacterial products for healthcare (patches, bandages), hygiene (insoles), cleaning and food industry. The company also produces unique machines for polymerisation of nanolayers at textile materials 'INM Foulard' and exclusively distributes unique patented electrospinning devices 'MultiSpin' and electrospinning devices clima control units 'ClimaSpin'.
The company's lead product in development is Amorphous Nano-Hydroxyapaite Powder. Nano-structured hydroxyapatite has several advantages over hydroxyapatite of larger particle size in its use in bone tissue engineering due to its higher surface area and consequently higher reactivity, which offers better cellular response. In addition, nano-sized hydroxyapatite is useful as an effective surface modification agent for binding numerous biological molecules.
Design, synthesis and manufacture of biocompatible nanoparticles called nanocells.
Mirexus Inc. is a natural biomaterials company that is commercializing a novel nanotechnology based on polysaccharide nanoparticles that can be used in a wide variety of markets ranging from cosmetics to nutraceuticals to biomedical applications in animal and human health. This technology was originally developed at the University of Guelph in the laboratories of Professor John Dutcher.
left arrowBack to Nanotechnology Links Directory